T.A.M. De Alencar et al. / Mutation Research 582 (2005) 105–115 115
E. Thomine, J. Wechsler, A prospective study of cutaneous in-
tolerance to topical mechlorethamine therapy in patients with
cutaneous T-cell lymphomas. French Study Group of Cuta-
neous Lymphomas, Arch. Dermatol. 135 (11) (1999) 1349–
1353.
[6] J.L. Ater, J. van Eys, S.Y. Woo, B. Moore III, D.R. Copeland,
J. Bruner, MOPP chemotherapy without irradiation as primary
postsurgical therapy for brain tumors in infants and young chil-
dren, Neurooncology 32 (3) (1997) 243–252.
[7] A. Masta, P.J. Gray, D.R. Phillips, Molecular bases of nitrogen
mustardeffectson transcription processes: role of depurination,
Nucleic Acids Res. 22 (19) (1994) 3880–3886.
[8] E.C. Friedberg, G.C. Walker, W. Siede (Eds.), DNA Repair and
Mutagenesis, ASM Press, Washington, DC, USA, 1995.
[9] S. Balcome, S. Park, D.R. Quirk Dorr, L. Hafner, L. Phillips,
N. Tretyakova, Adenine-containing DNA–DNA cross-links of
antitumor nitrogen mustards, Chem. Res. Toxicol. 17 (2004)
950–962.
[10] K.W. Kohn, C.L. Spears, P. Doty, Inter-strand crosslinking
of DNA by nitrogen mustard, J. Mol. Biol. 19 (1966) 266–
288.
[11] K.W. Kohn, N.H. Steigbigel, C.L. Spears, Cross-linking and
repair of DNAin sensitive and resistantstrains ofE. coli treated
with nitrogen mustard, Biochemistry 53 (1965) 1154–1161.
[12] M.L.G. Dronkert, R. Kanaar, Repair of DNA interstrand cross-
links, Mutat. Res. 486 (2001) 217–247.
[13] A. Ruhland, M. Brendel, Mutagenesis by cytostatic alkylating
agents in yeast strains of differing repair capacities, Genetics
92 (1979) 83–97.
[14] K.W. Kohn, D.M. Green, Transforming activity of nitrogen
mustard-crosslinked DNA, J. Mol. Biol. 19 (1966) 289–302.
[15] J. Miller, A Short Course in Bacterial Genetics, Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1992.
[16] J.P.H. Wijen, M.J.M. Nivard, E.W. Vogel, The in vivo
genetic activity profile of the monofunctional mustard 2-
chloroethylamine differs drastically from its bifunctional
counterpart mechlorethamine, Carcinogenesis 21 (10) (2000)
1859–1867.
[17] M. Cupido, B.A. Bridges, Uvr-independent repair of 8-
methoxypsoralen crosslinks in Escherichia coli: evidence for
a recombination process, Mutat. Res. 146 (1985) 135–141.
[18] P. Howard–Flanders, R.P. Boyce, L. Theriot, Three loci in
Escherichia coli K12 that control the excision of pyrimidine
dimers and certain other mutagen products from DNA, Genet-
ics 53 (1966) 1119–1136.
[19] W.A. Franklin, W.A. Haseltine, Removal of UV light-induced
pyrimidine-pyrimidone (6-4) products from Escherichia coli
DNA requires the uvrA, uvrB, and uvrC gene products, Proc.
Natl. Acad. Sci. U.S.A. 81 (12) (1984) 3821–3824.
[20] P.C. Hanawalt, R.H. Haynes,Repair replication of DNA in bac-
teria: Irrelevance of chemical nature of base defect, Biochem.
Biophys. Res. Commun. 19 (4) (1965) 462–467.
[21] C. Lage, M. de P
´
adula, T.A.M. de Alencar, S.R.F. Gonc¸alves,
L.S. Vidal, J. Cabral-Neto, A.C. Leit
˜
ao, New insights on how
nucleotide excision repair could remove DNA adducts induced
by chemotherapeutic agents and psoralens plus UV-A (PUVA)
in Escherichia coli, Mutat. Res. Rev. 544 (2003) 143–157.
[22] E.Y. Oh, L. Grossman, Helicase properties of the Escherichia
coli UvrA
2
B protein complex, Proc. Natl. Acad. Sci. U.S.A. 84
(1987) 3638–3642.
[23] Y.Zou, B. VanHouten, Strandopening by the UvrA
2
Bcomplex
allowsdynamic recognitionofDNAdamage,EmboJ.18 (1999)
4889–4901.
[24] M. Berardini, W. Mackay, E.L. Loechler, Evidence for a
recombination-independent pathway for the repair of DNA in-
terstrandcross-linksbasedon a site-specific study withnitrogen
mustard, Biochemistry 36 (1997) 3506–3513.
[25] A. Snowden, Y.W. Kow, B. Van Houten, Damage repertoire of
theEscherichiacoli UvrABC nuclease complexincludes abasic
sites, base-damage analogues, and lesions containing adjacent
5
or 3
nicks, Biochemistry 29 (31) (1990) 7251–7259.
[26] R.C. de Oliveira, J. Laval, S. Boiteux, Induction of SOS and
adaptive responses byalkylating agents in Escherichiacoli mu-
tants deficient in 3-methyladenine-DNA glycosylase activities,
Mutat. Res. 183 (1986) 11–20.
[27] B. Singer, D. Grunberger, Molecular Biology of Mutagens &
Carcinogens, Plenum Press, New York, USA, 1983.
[28] N. Brooks, P.J. McHugh, M. Lee, J.A. Hartley, The role of base
excision repair in the repair of DNA adducts formed by a series
of nitrogen mustard-containing, analogues of distamycin of in-
creasing binding site size, Anti-Cancer Drug Design 14 (1999)
11–18.